glp 1 diets Cigna drops employee coverage of GLP-1 obesity drugs GLP-1 Weight Loss Drugs: Coverage

In adults with overweight or obesity (without diabetes) the semaglutide 2.4 mg dose produced an average weight reduction of about 15% of baseline body weight over ~68 weeks in the STEP 1 trial, a result that surprised many clinicians because it brought pharmacologic outcomes into a range previously associated with surgical interventions

On April 30, 2026, the FDA proposed to exclude semaglutide, tirzepatide, and liraglutide from the 503B bulks list entirely, citing no clinical need for large-scale compounding now that FDA-approved supply is stable

iSatori L-Carnitine is a delicious water- enhancing concentrated drink mix that delivers three advanced forms of L-Carnitine in every serving

If you cannot use retatrutide, or you need a different option, these FDA-approved drugs are safe and good

Promuovere la salute neurologica: protegge i neuroni e supporta la rigenerazione nervosa